Menu

Nature Debuts Peer-Review Option

Authors submitting to Nature journals can soon request double-blind reviews.

Feb 18, 2015
Tracy Vence

FLICKR, PETE O'SHEABeginning next month, authors submitting their work to Nature and its associated journals can request double-blind peer review, in which the authors’ names and affiliations will be withheld from reviewers (much like reviewers’ names and affiliations are currently withheld from the authors).

“Advocates of double-blind peer review suggest that it eliminates personal biases, such as those based on gender, seniority, reputation and affiliation,” Nature noted in its February 18 announcement.

In contrast, some researchers have advocated for open peer review, in which the authors and reviewers both are clearly identified, arguing that such increased transparency might further limit bias. But some open-peer-review advocates, such as PhD student Matthew Evans of the John Innes Centre in Norwich, U.K., suggest that, if reviews are to be blinded, double-blind is preferable to single-blind peer review.

“Good scientists will continue to publish good papers in good journals under a double-blind peer review system,” wrote Boyan Garvalov of Justus Liebig University Giessen, Germany, in a January Advances in Regenerative Biology article (hat tip: Alexis Verger). “But every now and again a lesser known research team could make it on the strength of their work against a more famous one, when they would have failed in the single-blind setting—and this would be reason enough for me to endorse the shift to double-blind review.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.